CN107714891A - A kind of composition for treating osteoproliferation and disc herniation - Google Patents
A kind of composition for treating osteoproliferation and disc herniation Download PDFInfo
- Publication number
- CN107714891A CN107714891A CN201711042130.1A CN201711042130A CN107714891A CN 107714891 A CN107714891 A CN 107714891A CN 201711042130 A CN201711042130 A CN 201711042130A CN 107714891 A CN107714891 A CN 107714891A
- Authority
- CN
- China
- Prior art keywords
- osteoproliferation
- disc herniation
- composition
- treatment
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 title claims abstract description 34
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 241001532036 Aspidistra Species 0.000 claims abstract description 9
- 235000008671 Calycanthus floridus Nutrition 0.000 claims abstract description 9
- 235000008670 Calycanthus occidentalis Nutrition 0.000 claims abstract description 9
- 244000146462 Centella asiatica Species 0.000 claims abstract description 9
- 235000004032 Centella asiatica Nutrition 0.000 claims abstract description 9
- 241000218176 Corydalis Species 0.000 claims abstract description 9
- 241000282326 Felis catus Species 0.000 claims abstract description 9
- 240000005702 Galium aparine Species 0.000 claims abstract description 9
- 235000014820 Galium aparine Nutrition 0.000 claims abstract description 9
- 235000004520 Lindera benzoin Nutrition 0.000 claims abstract description 9
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 claims abstract description 9
- 241000830536 Tripterygium wilfordii Species 0.000 claims abstract description 9
- 235000015398 thunder god vine Nutrition 0.000 claims abstract description 9
- 244000018716 Impatiens biflora Species 0.000 claims abstract description 8
- 235000007650 Aralia spinosa Nutrition 0.000 claims abstract description 5
- 241000949456 Zanthoxylum Species 0.000 claims abstract description 5
- 244000148992 Lindera benzoin Species 0.000 claims abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- 239000000463 material Substances 0.000 claims description 17
- 238000001802 infusion Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 235000014101 wine Nutrition 0.000 claims description 6
- 229920000881 Modified starch Polymers 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 229940099259 vaseline Drugs 0.000 claims description 3
- 235000020097 white wine Nutrition 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 238000002360 preparation method Methods 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 7
- 230000000202 analgesic effect Effects 0.000 abstract description 2
- 210000002808 connective tissue Anatomy 0.000 abstract description 2
- 206010020718 hyperplasia Diseases 0.000 abstract description 2
- 108010048734 sclerotin Proteins 0.000 abstract description 2
- 230000036592 analgesia Effects 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 11
- 206010005963 Bone formation increased Diseases 0.000 description 9
- 244000025311 Calycanthus occidentalis Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 238000000554 physical therapy Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000000306 recurrent effect Effects 0.000 description 3
- 244000144730 Amygdalus persica Species 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- 241001465251 Ephedra sinica Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000271309 Aquilaria crassna Species 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 241000489492 Arisaema Species 0.000 description 1
- 244000189799 Asimina triloba Species 0.000 description 1
- 235000006264 Asimina triloba Nutrition 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 241000123589 Dipsacus Species 0.000 description 1
- 241001074093 Echinopsis Species 0.000 description 1
- 208000002513 Flank pain Diseases 0.000 description 1
- 241000576429 Forsythia suspensa Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 241000096284 Gynochthodes officinalis Species 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 241000545744 Hirudinea Species 0.000 description 1
- 208000018650 Intervertebral disc disease Diseases 0.000 description 1
- 241000361919 Metaphire sieboldi Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000219099 Parthenocissus quinquefolia Species 0.000 description 1
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 244000272264 Saussurea lappa Species 0.000 description 1
- 235000006784 Saussurea lappa Nutrition 0.000 description 1
- 241000522620 Scorpio Species 0.000 description 1
- 235000003407 Sigesbeckia orientalis Nutrition 0.000 description 1
- 240000009022 Smilax rotundifolia Species 0.000 description 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 241001369613 Stephania tetrandra Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 240000004824 Trimezia steyermarkii Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- -1 are cleaned Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 239000009136 dragon's blood Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000010934 exostosis Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 201000010930 hyperostosis Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 208000021600 intervertebral disc degenerative disease Diseases 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000009490 scorpio Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000000273 spinal nerve root Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to drug preparation technique field, more particularly to a kind of composition for treating osteoproliferation and disc herniation；Including following raw material by weight：Tripterygium wilfordii 25~35, Radix Amydrii sinensis 25~35, Gotu Kola 25~35, catchweed bedstraw herb 25~35, fragrant spicebush bark or branchlet and leaf 25~35, aspidistra 25~35, balsamine 20~30, spinyleaf pricklyash root 20~30, alpine yallow herb 15~25, decumbent corydalis tuber 15~25, Radix Alangii 15~25, cat fur 10~20；The composition of the present invention is combined by the medicine with wind dispelling, dehumidifying, analgesia, dissolving stasis, analgesic efficacy, the sclerotin of hyperplasia can effectively be dissolved, prevent osteoproliferation, the connective tissue that interverbebral disc prominent (swollen) goes out can be cleared up, effectively reduce the occurrence frequency of osteoproliferation and disc herniation disease, reach the purpose for the treatment of osteoproliferation and disc herniation disease, suitable for various osteoproliferation and disc herniation disease.
Description
Technical field
The present invention relates to drug preparation technique field, more particularly to a kind of combination for treating osteoproliferation and disc herniation
Thing.
Background technology
Hyperostosis is mainly in above middle age.It is generally acknowledged that due to being had a delicate constitution after the middle age and retrogression；For a long time
Stand or walk and be held in certain posture for a long time, due to the drawing of muscle or avulsion, bleeding, organization of hematoma, form thorn-like
Or the osteoproliferation of lip sample；Spur to soft tissue produce it is mechanical stimulation and wound after soft tissue injury, bleeding, swelling and
Cause, including cervical vertebrae hyperosteogeny, lumbar vertebrae hyperosteogeny, articulatio genus hyperosteogeny；The protrasion of the lumbar intervertebral disci is relatively conventional disease
One of suffer from, lumber ertebral disc each several part (nucleus pulposus, fibrous ring and cartilage plate), especially nucleus pulposus are primarily due to, is had different degrees of
After degenerative change, in the presence of external force factor, the Anular disruption of interverbebral disc, nucleus pulposus from rupture part it is prominent (or
Abjection) in rear or intraspinal tube, cause adjacent spinal nerve root to be stimulated or oppressed, so as to produce flank pain, side lower limb
A series of or clinical symptoms such as double lower limb numbness, pain.At present, treatment of the doctor trained in Western medicine for osteoproliferation and disc herniation is adopted more
Medicine is based on antibiotic, hormone, anodyne, and physiotherapy is with partial insulation, physiotherapy, acupuncture, massage, though so contribute to fast
Quick-recovery, slow down pain, its short run effect is fine, but can not remove root.Drug therapy is carried out for the more long patient of stadium,
But prolonged administration of drugs can not only develop immunity to drugs, it is disorderly also to produce such as gastrointestinal function damage, osteoporosis, endocrine
Disorderly, the adverse reaction such as nervous system disorders and cortin hyperfunction, and root can not be thoroughly removed, and use physiotherapy, then need to grow
Time adheres to, it is impossible to interrupts, but is not easy to effect a radical cure, and because tcm therapy has Small side effects, anti-recurrence rate effect is good, can be steady
Determine the state of an illness, indiffusible feature so that it has obtained quick application in osteoproliferation and disc herniation disease areas and pushed away
Extensively, still, because the traditional Chinese medical science of the prior art formula is unreasonable, material composition is incorrect, causes current osteoproliferation and intervertebral
The therapeutic effect that disk protrudes disease is not notable, and cure rate is relatively low.There are research treatment osteoproliferation and disc herniation in the country at present
Chinese medicine preparation, and certain effect is achieved, such as application number CN201410349985.9 invention《A kind of medicine for treating hyperosteogeny》
A kind of medicine for treating hyperosteogeny is disclosed, the medicine for treating hyperosteogeny is made up of the medicinal material of following parts by weight:Chinese ephedra 30-33, cassia twig 10-
15th, root of fangji 20-25, rheum officinale 40-48, licorice 10, pawpaw 10-16, the capsule of weeping forsythia 10, radix ampelopsis 16, agalloch eaglewood 13-16, rattletop 16, bark of ash
10th, safflower 5, peach kernel 5-10, radix cyathulae 10-16, radix scutellariae 10, Radix Rhapontici seu Radix Echinopsis 10-15, Radix Angelicae Sinensis 10-15 and costus root 10-16；Such as application
Number CN201310293008.7 invention《Treat the Chinese medicine preparation of disc herniation》Disclose a kind of disc herniation for the treatment of
Chinese medicine preparation, it is characterized in that made of the raw material of following weight proportion：Leech 3-5 parts；Scorpio 8-10, dragon's blood 15-20, Chinese ephedra
8-10, earthworm 8-10, arisaema cum bile 3-5, teasel 15-20, peach kernel 15-20, Semen Strychni (processed) 5-8, Radix Angelicae Sinensis 15-20, Morinda officinalis 5-
8th, Common St.Paulswort Herb 5-8, rhizome of Maire Greenbrier 8-10, Stephania tetrandra 8-10, coix seed 12-25, ground bettle 4-7, cassia twig 8-10, catechu 8-10, Shen
Ginger 8-10, bark of ash 15-20, rhizoma homalonemae 15-20, the extra large 8-10 in side, caulis trachelospermi 15-20, Sichuan troops 15-20.But due to prior art
In the traditional Chinese medical science formula it is unreasonable, material composition is incorrect, causes the treatment at present for osteoproliferation and disc herniation disease
Effect is not notable, and improvement rate is relatively low.
The content of the invention
The present invention is in order to solve the above technical problems, provide a kind of composition for treating osteoproliferation and disc herniation.
Realized particular by following technical scheme：
A kind of composition for treating osteoproliferation and disc herniation, including following raw material by weight：Tripterygium wilfordii
25~35, Radix Amydrii sinensis 25~35, Gotu Kola 25~35, catchweed bedstraw herb 25~35, fragrant spicebush bark or branchlet and leaf 25~35, aspidistra 25~35, phoenix
Celestial being spends 20~30, spinyleaf pricklyash root 20~30, alpine yallow herb 15~25, decumbent corydalis tuber 15~25, Radix Alangii 15~25, cat fur 10~20.
Including following raw material by weight：Tripterygium wilfordii 30, Radix Amydrii sinensis 30, Gotu Kola 30, catchweed bedstraw herb 30, fragrant spicebush bark or branchlet and leaf
30th, aspidistra 30, balsamine 25, spinyleaf pricklyash root 25, alpine yallow herb 20, decumbent corydalis tuber 20, Radix Alangii 20, cat fur 15.
Described composition, for agent of steeping in wine, oral solutions, pill, paste.
Described agent of steeping in wine, be after raw material is cleaned, immersion sealed with alcoholic strength >=50%vol white wine, summer extremely
15d is soaked less, at least soaks 30d in the winter time.
Described oral solutions, it is after raw material is weighed, cleans, crush, add the water of 3~4 times of the crushed material quality,
Infusion 40min is heated, adds the ethanol of 10 times of amounts of crushed material quality, it is quiet after supersound process 15min under 50KHz frequency
1~2h is put, ethanol is reclaimed, heels is filtered, obtains filtrate, then filter residue repetition is added into water infusion twice, each 30min, by three
Secondary filtrate mixing, which is concentrated into, mixes the 1/2 of filtrate volume, and the sugar content for adjusting concentrate is 20%, packaging.
Described pill, it is to weigh raw material, cleans, crush, adds 20% pregelatinized starch of total amount, then with 75%
Ethanol infiltration, be granulated by comminutor, particle be made, sieve, obtain pill.
Described paste, it is after raw material is weighed, cleans, crush, adds the water of 1~2 times of the crushed material quality, heating
Infusion 30min, the ethanol of 5 times of amounts of the crushed material quality are added, be ultrasonically treated under 50KHz frequency after 12min and stand 1~
2h, ethanol is reclaimed, heels continued to heat, infusion obtains the medicinal extract that water content is 20%, adds the 40% of medicinal extract quality
Vaseline, mix, cooling.
In summary, the beneficial effects of the present invention are：The composition of the present invention by with wind dispelling, dehumidifying, ease pain, dispel
The stasis of blood, the medicine of analgesic efficacy are combined, and can effectively be dissolved the sclerotin of hyperplasia, be prevented osteoproliferation, can clear up interverbebral disc and dash forward
The connective tissue that (swollen) goes out, the occurrence frequency of osteoproliferation and disc herniation disease is effectively reduced, reaches treatment osteoproliferation
With the purpose of disc herniation disease, suitable for various osteoproliferation and disc herniation disease, composition of the invention, it is controlled
Therapeutic effect is notable, and more than 94%, patient more than 97%, while avoids using doctor trained in Western medicine clinical improvement rate to drug absorption rate
The pain brought to patient, have no side effect after treatment, Chinese medicine material uneasy to recur and easy to operate while selected holds
Easily obtain, and it is cheap.
Embodiment
The embodiment of the present invention is described in further detail below, but the invention is not limited in these realities
Mode is applied, any improvement or replacement on the present embodiment essence spirit, it is claimed to still fall within the claims in the present invention
Scope.
Embodiment 1
A kind of composition for treating osteoproliferation and disc herniation, including following raw material by weight：Tripterygium wilfordii
25kg, Radix Amydrii sinensis 25kg, Gotu Kola 25kg, catchweed bedstraw herb 25kg, fragrant spicebush bark or branchlet and leaf 25kg, aspidistra 25kg, balsamine 20kg, see blood
Fly 20kg, alpine yallow herb 15kg, decumbent corydalis tuber 15kg, Radix Alangii 15kg, cat fur 10kg.
Described treatment osteoproliferation and the composition of disc herniation, its preparation method are after raw material is cleaned, to use wine
The white wine sealing immersion that precision is 50%vol, 15d is at least soaked in summer, at least soaks 30d in the winter time, must steep in wine agent.
Application method：The daily morning and evening takes once respectively, every time 30~40ml.
Embodiment 2
A kind of composition for treating osteoproliferation and disc herniation, including following raw material by weight：Tripterygium wilfordii
35kg, Radix Amydrii sinensis 35kg, Gotu Kola 35kg, catchweed bedstraw herb 35kg, fragrant spicebush bark or branchlet and leaf 35kg, aspidistra 35kg, balsamine 30kg, see blood
Fly 30kg, alpine yallow herb 25kg, decumbent corydalis tuber 25kg, Radix Alangii 25kg, cat fur 20kg.
Described treatment osteoproliferation and the composition of disc herniation, its preparation method are after raw material is weighed, and are cleaned,
Crush, add the water of 3~4 times of the crushed material quality, heat infusion 40min, add the second of 10 times of amounts of crushed material quality
Alcohol, 1~2h is stood after 15min is ultrasonically treated under 50KHz frequency, ethanol is reclaimed, heels is filtered, obtain filtrate, then will
Filter residue is repeated to add water infusion twice, each 30min, and filtrate three times is mixed and is concentrated into the 1/2 of mixing filtrate volume, regulation concentration
The sugar content of liquid is 20%, packs and produces oral solutions.
Application method：Take respectively once in the morning, afternoon and evening daily, every time 60~70ml.
Embodiment 3
A kind of composition for treating osteoproliferation and disc herniation, including following raw material by weight：Tripterygium wilfordii
30kg, Radix Amydrii sinensis 30kg, Gotu Kola 30kg, catchweed bedstraw herb 30kg, fragrant spicebush bark or branchlet and leaf 30kg, aspidistra 30kg, balsamine 25kg, see blood
Fly 25kg, alpine yallow herb 20kg, decumbent corydalis tuber 20kg, Radix Alangii 20kg, cat fur 15kg.
Described treatment osteoproliferation and the composition of disc herniation, its preparation method are to weigh raw material, are cleaned, powder
It is broken, 20% pregelatinized starch of total amount is added, then infiltrated with 75% ethanol, it is granulated by comminutor, particle, mistake is made
Sieve, obtains pill.
Application method：Take respectively once in the morning, afternoon and evening daily, 1~2 every time.
Embodiment 4
A kind of composition for treating osteoproliferation and disc herniation, including following raw material by weight：Tripterygium wilfordii
25kg, Radix Amydrii sinensis 35kg, Gotu Kola 25kg, catchweed bedstraw herb 35kg, fragrant spicebush bark or branchlet and leaf 30kg, aspidistra 30kg, balsamine 20kg, see blood
Fly 30kg, alpine yallow herb 20kg, decumbent corydalis tuber 20kg, Radix Alangii 15kg, cat fur 20kg.
Described treatment osteoproliferation and the composition of disc herniation, its preparation method are after raw material is weighed, and are cleaned,
Crush, add the water of 1~2 times of the crushed material quality, heat infusion 30min, add the second of 5 times of amounts of crushed material quality
Alcohol, 1~2h is stood after 12min is ultrasonically treated under 50KHz frequency, ethanol is reclaimed, heels is continued to heat, infusion must contain
Water is 20% medicinal extract, adds 40% vaseline of medicinal extract quality, mixes, cools down and produce paste.
Application method：Use once every three days, every time in use, by paste application around affected part, immobilization with adhesive tape is
Can.
1st, randomly select similar symptom osteoproliferation and disc herniation patient it is some, be randomly divided into 4 groups, adopt respectively
The composition prepared with embodiment 1~4 is treated, and the applicant tracks follow-up, counts the improvement situation of patient and to medicine
The absorbing state of thing, as a result as shown in table 1：
Table 1
| Project | Improvement rate % | Drug absorption rate % |
| Embodiment 1 | 95.5 | 98.6 |
| Embodiment 2 | 94.8 | 98.1 |
| Embodiment 3 | 94.2 | 97.9 |
| Embodiment 4 | 95.2 | 98.4 |
2nd, efficacy test example：The present invention takes safety, easy to operate, evident in efficacy, efficient high, and is clinical data institute
Prove, the relevant clinical data of the present invention is as follows：
1st, Song：50 years old, man, made a definite diagnosis in November, 2015 concurrent with articulatio genus hyperosteogeny and protrusion of lumber intervertebral disc
Disease, the therapeutic modality being combined using doctor trained in Western medicine, physiotherapy, 1 year is continue for, during which recurrent exerbation, after taking 10d by top, pain
Sense slows down, and continues after taking 1 course for the treatment of, and pain disappears, each course for the treatment of one month.
2nd, Hu：55 years old, man, make a definite diagnosis in January, 2014 with lumbar vertebrae hyperosteogeny, be combined using doctor trained in Western medicine, physiotherapy
Therapeutic modality, 2 years are continue for, during which recurrent exerbation, after taking a course for the treatment of by top, pain slows down, and continues to take 1
After the course for the treatment of, pain disappears, and does not recur again, each course for the treatment of one month.
3rd, Mr. Wang：58 years old, female was made a definite diagnosis in March, 2015 with cervical vertebra and lumbar vertebrae hyperosteogeny complication, using west
The therapeutic modality that doctor, physiotherapy are combined, continue for three months, during which recurrent exerbation, and after taking 10d by top, pain slows down,
Continue after taking 1 course for the treatment of, pain disappears, and does not recur again, each course for the treatment of one month.
So far, patient body is healthy always for the present inventor's follow-up, and the incidence of disease persistently reduces, and the pain fallen ill every time is gradually
Decline, wherein, improvement rate is more than 98%.
Claims (7)
1. a kind of composition for treating osteoproliferation and disc herniation, it is characterised in that including following original by weight
Material：Tripterygium wilfordii 25~35, Radix Amydrii sinensis 25~35, Gotu Kola 25~35, catchweed bedstraw herb 25~35, fragrant spicebush bark or branchlet and leaf 25~35, aspidistra
25~35, balsamine 20~30, spinyleaf pricklyash root 20~30, alpine yallow herb 15~25, decumbent corydalis tuber 15~25, Radix Alangii 15~25, cat skin
Hair 10~20.
2. the composition for the treatment of osteoproliferation and disc herniation as claimed in claim 1, it is characterised in that including pressing below
The raw material of parts by weight meter：Tripterygium wilfordii 30, Radix Amydrii sinensis 30, Gotu Kola 30, catchweed bedstraw herb 30, fragrant spicebush bark or branchlet and leaf 30, aspidistra 30, balsamine
25th, spinyleaf pricklyash root 25, alpine yallow herb 20, decumbent corydalis tuber 20, Radix Alangii 20, cat fur 15.
3. the composition for the treatment of osteoproliferation and disc herniation as claimed in claim 1, it is characterised in that described combination
Thing, for agent of steeping in wine, oral solutions, pill, paste.
4. the composition for the treatment of osteoproliferation and disc herniation as claimed in claim 3, it is characterised in that described steeps in wine
Agent, it is after raw material is cleaned, seals immersion with alcoholic strength >=50%vol white wine, 15d is at least soaked in summer, in the winter time extremely
30d is soaked less.
5. the composition for the treatment of osteoproliferation and disc herniation as claimed in claim 3, it is characterised in that described is oral
Liquor, it is after raw material is weighed, cleans, crush, add the water of 3~4 times of the crushed material quality, heat infusion 40min, add
The ethanol of 10 times of amounts of crushed material quality, stands 1~2h after 15min is ultrasonically treated under 50KHz frequency, reclaims ethanol,
Heels is filtered, obtains filtrate, then by filter residue repeat plus water infusion twice, each 30min, will three times filtrate mix be concentrated into it is mixed
With the 1/2 of filtrate volume, the sugar content for adjusting concentrate is 20%, packaging.
6. the composition for the treatment of osteoproliferation and disc herniation as claimed in claim 3, it is characterised in that described ball
Agent, it is to weigh raw material, cleans, crush, add 20% pregelatinized starch of total amount, then infiltrated with 75% ethanol, is passed through
Comminutor is granulated, and particle is made, and is sieved, is obtained pill.
7. the composition for the treatment of osteoproliferation and disc herniation as claimed in claim 3, it is characterised in that described cream
Agent, it is after raw material is weighed, cleans, crush, add the water of 1~2 times of the crushed material quality, heat infusion 30min, add institute
The ethanol of 5 times of amounts of crushed material quality is stated, 1~2h is stood after 12min is ultrasonically treated under 50KHz frequency, reclaims ethanol, will be residual
Clout continues to heat, and infusion obtains the medicinal extract that water content is 20%, adds 40% vaseline of medicinal extract quality, mixes, cooling
.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711042130.1A CN107714891A (en) | 2017-10-29 | 2017-10-29 | A kind of composition for treating osteoproliferation and disc herniation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711042130.1A CN107714891A (en) | 2017-10-29 | 2017-10-29 | A kind of composition for treating osteoproliferation and disc herniation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107714891A true CN107714891A (en) | 2018-02-23 |
Family
ID=61202389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711042130.1A Pending CN107714891A (en) | 2017-10-29 | 2017-10-29 | A kind of composition for treating osteoproliferation and disc herniation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107714891A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107050137A (en) * | 2017-03-29 | 2017-08-18 | 贵州银老太侗医药有限公司 | A kind of composition for treating neck, shoulder, lumbar disc disease and preparation method thereof |
-
2017
- 2017-10-29 CN CN201711042130.1A patent/CN107714891A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107050137A (en) * | 2017-03-29 | 2017-08-18 | 贵州银老太侗医药有限公司 | A kind of composition for treating neck, shoulder, lumbar disc disease and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 韩仲成: "《随印会河待诊记》", 31 August 2012, 中国中医药出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102488869B (en) | Traditional Chinese medicinal external-use liniment for muscle and bone ache | |
| CN100423761C (en) | Chinese medicinal preparation for treating fracture, traumatic injury | |
| CN1824009B (en) | Multipurpose medicinal composition capable of oral administration and external use | |
| CN102552608B (en) | Medicine composition used for treating fracture and bone injury, preparation method thereof, and purpose thereof | |
| CN107007714A (en) | It is a kind of that there is the exterior-applied medical wine for promoting poroma nucleus formation | |
| CN103784550B (en) | For Chinese medicine composition and the preparation thereof of swelling and pain relieving | |
| CN104706782A (en) | External tincture for treating bone poliomyelitis and preparation method of external tincture | |
| CN107050138A (en) | Pharmaceutical composition and its preparation and paste preparation method for treating osteoproliferation | |
| CN107714891A (en) | A kind of composition for treating osteoproliferation and disc herniation | |
| CN106511905A (en) | Traditional Chinese medicine preparation used for curing cervical spondylosis and preparation method thereof | |
| CN103585294B (en) | A kind of for plaster treating hyperosteogeny and preparation method thereof | |
| CN106177002A (en) | A kind of medicated powder medicated wine complex treating bone matrix hyperplasia | |
| CN101708292A (en) | Chinese medicament for treating rheumatic and rheumatoid diseases | |
| CN109908246A (en) | The external application Chinese medicine formula for treating lumbar pain orthopaedic disease | |
| CN103191342B (en) | Method for preparing diaphyseal aclasis nursing substance | |
| CN117357608B (en) | External application medicine for treating traumatic injury and fracture and tendon injury | |
| CN103191343B (en) | Pharmaceutical composition for treating diaphyseal aclasis | |
| CN108355092A (en) | Treat the cream of activating blood and relaxing tendons of rheumatic pain of neck, shoulder, waist and leg | |
| CN107617098A (en) | One kind treats psoriasic composition | |
| CN108079195A (en) | Treat the Chinese medicine composition of orthopaedic disease | |
| CN115227765B (en) | Preparation and application of uterus warming three-volt patch for treating dysmenorrhea | |
| CN102178845B (en) | Plaster for treating spur and preparation method thereof | |
| CN107260828A (en) | Pharmaceutical composition for treating closed soft tissue injury and injured bones and muscles | |
| CN106692821A (en) | Traditional Chinese medicine preparation for treating neurosurgical postoperative headache | |
| CN110141643A (en) | Treat prolapse of lumbar intervertebral disc, the anaesthetic composition of rheumatic arthritis and its application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180223 |
|
| RJ01 | Rejection of invention patent application after publication |